Latest filing published 01 Dec 2023 for Genscript Biotech Corporation.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Guo Hongxin: trading record in brief
Guo Hongxin appears in our data through filings on Genscript Biotech Corporation shares, published by HKEX. Over a trading history stretching from 29 November 2018 to 28 November 2023, the count stands at 6 filings.
Market trades split into 4 purchases and 1 sale (€921k). The totals do not cover 4 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2023 to date brings 2 purchases and 1 sale.
On 1 December 2023 came the latest disclosure, an open-market purchase in Genscript Biotech Corporation. Filings reach the HKEX feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Guo Hongxin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 34,409 sharesShareXHKGHKEX:DA20231201E00164Canonical exit: 26 Feb 2024 (T+90)
- 338,316 shares@ HK$22.729757.8% of flowShareXHKGHKEX:DA20231116E00345
- 400,000 shares@ HK$14.0442.2% of flowShareXHKGHKEX:DA20231116E00344
- 14,929 sharesShareXHKGHKEX:DA20230126E00496Canonical exit: 18 Apr 2023 (T+90)
- 60,000 sharesShareXHKGHKEX:DA20200903E00408Canonical exit: 30 Nov 2020 (T+90)
- 400,000 sharesShareXHKGHKEX:DA20190127E00055Canonical exit: 27 Feb 2019 (T+90)
6 of 6 declarations
